Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) EBITDA (2016 - 2025)

Healthstream (HSTM) has disclosed EBITDA for 16 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA fell 48.7% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $20.2 million, a 4.94% decrease, with the full-year FY2025 number at $24.1 million, down 3.79% from a year prior.
  • EBITDA was $2.4 million for Q4 2025 at Healthstream, down from $7.6 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $7.6 million in Q3 2025 to a low of -$6.9 million in Q4 2021.
  • A 5-year average of $3.1 million and a median of $4.0 million in 2022 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: tumbled 705.45% in 2021, then soared 169.83% in 2023.
  • Healthstream's EBITDA stood at -$6.9 million in 2021, then rose by 11.45% to -$6.1 million in 2022, then skyrocketed by 169.83% to $4.3 million in 2023, then grew by 10.12% to $4.7 million in 2024, then crashed by 48.7% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's EBITDA are $2.4 million (Q4 2025), $7.6 million (Q3 2025), and $5.9 million (Q2 2025).